When innovation outpaces regulations: The legal challenges for direct‐to‐patient supply of investigational medicinal products - Malone - 2022 - British Journal of Clinical Pharmacology - Wiley Online Library
GMP for IMPs in View of the Revision of the EU Clinical Trial Provisions
EudraLex Volume 4: EU Annex 21 GMP guidelines
Support - EMA
EudraLex - Volume 10 - Clinical trials guidelines UPDATED
Frontiers | Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective
Pharmaceutics | Free Full-Text | Critical Analysis and Quality Assessment of Nanomedicines and Nanocarriers in Clinical Trials: Three Years of Activity at the Clinical Trials Office
EudraLex - Volume 10 - Clinical trials guidelines UPDATED
Medical Writing | Public Disclosure | Clinical trial results disclosure on ClinicalTrials.gov and EudraCT
New documents in EudraLex Volume 10 Clinical trials guidelines including an updated CTA form
CTIS for authorities - EMA
Publication of Good Lay Summary Practice (GLSP) Recommendations | Ecrin
Being Inspection Ready: Top Tips And Warnings.
EudraLex - Volume 10 - Clinical trials guidelines UPDATED
Eudralex Vol 10 PDF | PDF | Healthcare Industry | Pharmacy
GVR Consultancy by Gerald Van Roey - Links
EudraLex - Volume 10 - Clinical trials guidelines UPDATED
Transparency: The EU Prospective
Tips for Clinical Trial Sponsors: Regulation (EU) No 536/201420
Update on the Clinical Trials Regulation (EU) No 536/2014 - Key developments
Clinical Trials Regulation (CTR) for medicinal products in application on 31 January 2022
EudraLex - Volume 4 - Good Manufacturing Practice (GMP) guidelines - Free PDF download | M A N O X B L O G
